People: Catalyst Pharmaceutical Partners Inc (CPRX.OQ)

CPRX.OQ on NASDAQ Stock Exchange Capital Market

2.85USD
1:24pm EDT
Price Change (% chg)

$0.14 (+5.17%)
Prev Close
$2.71
Open
$2.72
Day's High
$2.90
Day's Low
$2.72
Volume
124,414
Avg. Vol
326,998
52-wk High
$3.49
52-wk Low
$1.30

Search Stocks

McEnany, Patrick 

Brief Biography

Mr. Patrick J. McEnany is the Chairman of the Board, President, Chief Executive Officer of Catalyst Pharmaceutical Partners, Inc. Mr. McEnany has been CEO and a director since formation in January 2002. He became Chairman and President in March 2006. From 1999 to 2002, Mr. McEnany was a consultant to the pharmaceutical industry. From 1991 to 1997, Mr. McEnany was Chairman and CEO of Royce Laboratories, Inc., a generic pharmaceutical manufacturer. From 1997 to 1998, after the merger of Royce into Watson Pharmaceuticals, Inc., Mr. McEnany served as president of the wholly-owned Royce Laboratories subsidiary and vice president of corporate development for Watson Pharmaceuticals, Inc. From 1993 to 1997, he also served as vice chairman and a director of the National Association of Pharmaceutical Manufacturers. He currently serves on the board of directors for ThermoGenesis Corp. and the Jackson Memorial Hospital Foundation, and over the last 30 years has served as a director for numerous other public companies.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
426,512 -- -- 426,512

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Patrick McEnany

426,512

Alicia Grande

239,800

Steven Miller

318,806

David Muth

--

M. Douglas Winship

258,429

David Caponera

--
As Of 30 Dec 2013
Search Stocks